In p53-deficient cells, depletion of MDM2 disrupts serine/glycine metabolism, the NAD+/NADH ratio, and glutathione (GSH) recycling, adversely affecting redox balance and tumor growth (Riscal et al., 2016). The gene discussed is TP53; the disease is neoplasm.